S Stojanov

2.3k total citations
36 papers, 1.4k citations indexed

About

S Stojanov is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, S Stojanov has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Immunology and 9 papers in Hematology. Recurrent topics in S Stojanov's work include Inflammasome and immune disorders (21 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and IL-33, ST2, and ILC Pathways (7 papers). S Stojanov is often cited by papers focused on Inflammasome and immune disorders (21 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and IL-33, ST2, and ILC Pathways (7 papers). S Stojanov collaborates with scholars based in Germany, United States and France. S Stojanov's co-authors include Daniel L. Kastner, Bernd H. Belohradsky, Michael McDermott, Elke Lainka, Ulrich Neudorf, Seza Özen, Tim Niehues, Christian Timmann, B. H. Belohradsky and Kristina Huß and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PEDIATRICS and Annals of the Rheumatic Diseases.

In The Last Decade

S Stojanov

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Stojanov Germany 19 1.1k 566 370 237 210 36 1.4k
Maura Rossetti United States 24 277 0.3× 580 1.0× 107 0.3× 245 1.0× 108 0.5× 90 1.6k
Marie‐Alexandra Alyanakian France 20 352 0.3× 548 1.0× 111 0.3× 148 0.6× 149 0.7× 34 1.4k
J. Sieper Germany 18 199 0.2× 897 1.6× 611 1.7× 123 0.5× 24 0.1× 84 2.3k
Kenichi Negoro Japan 20 306 0.3× 659 1.2× 103 0.3× 400 1.7× 16 0.1× 45 1.6k
Oriano Radillo Italy 19 140 0.1× 612 1.1× 84 0.2× 151 0.6× 24 0.1× 51 1.1k
Mandakolathur R. Murali United States 14 267 0.3× 846 1.5× 93 0.3× 120 0.5× 53 0.3× 39 1.7k
H Chapel United Kingdom 18 99 0.1× 614 1.1× 189 0.5× 291 1.2× 19 0.1× 28 1.2k
T Miyawaki Japan 16 177 0.2× 489 0.9× 181 0.5× 158 0.7× 37 0.2× 20 945
Marilyn Marrari United States 26 161 0.2× 1.1k 2.0× 207 0.6× 226 1.0× 183 0.9× 76 2.0k
G. D. Pegrum United Kingdom 19 143 0.1× 246 0.4× 214 0.6× 93 0.4× 33 0.2× 83 1.0k

Countries citing papers authored by S Stojanov

Since Specialization
Citations

This map shows the geographic impact of S Stojanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Stojanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Stojanov more than expected).

Fields of papers citing papers by S Stojanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Stojanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Stojanov. The network helps show where S Stojanov may publish in the future.

Co-authorship network of co-authors of S Stojanov

This figure shows the co-authorship network connecting the top 25 collaborators of S Stojanov. A scholar is included among the top collaborators of S Stojanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Stojanov. S Stojanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luchting, Benjamin, et al.. (2023). Interdisziplinäre multimodale Schmerztherapie bei postviralen Syndromen und ME/CFS. Der Schmerz. 38(3). 183–189. 1 indexed citations
2.
Vanoni, Federica, Roberta Caorsi, Jordi Antón, et al.. (2018). Towards a new set of classification criteria for PFAPA syndrome. Pediatric Rheumatology. 16(1). 60–60. 33 indexed citations
3.
Piram, Maryam, Isabelle Koné‐Paut, Helen J. Lachmann, et al.. (2013). Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes. Annals of the Rheumatic Diseases. 73(12). 2168–2173. 91 indexed citations
4.
Lainka, Elke, P Lohse, Christian Timmann, et al.. (2012). Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. European Journal of Pediatrics. 171(12). 1775–1785. 19 indexed citations
5.
Lainka, Elke, Ulrich Neudorf, P Lohse, et al.. (2011). Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children. Rheumatology International. 32(10). 3253–3260. 22 indexed citations
6.
Morbach, Henner, et al.. (2009). Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment. Rheumatology International. 30(2). 207–212. 13 indexed citations
7.
Lainka, Elke, Ulrich Neudorf, P Lohse, et al.. (2009). Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Lara D. Veeken. 48(8). 987–991. 34 indexed citations
10.
Kallinich, Tilmann, Dieter Haffner, Tim Niehues, et al.. (2007). Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement. PEDIATRICS. 119(2). e474–e483. 177 indexed citations
11.
Rack, Anita, S Stojanov, Bernd H. Belohradsky, & Peter Lohse. (2006). A new low‐penetrance TNFRSF1A mutation causing atypical periodic fever. Pediatrics International. 48(2). 169–171. 2 indexed citations
12.
Stojanov, S & Michael McDermott. (2005). the tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Reviews in Molecular Medicine. 7(22). 1–18. 60 indexed citations
13.
Stojanov, S & Daniel L. Kastner. (2005). Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Current Opinion in Rheumatology. 17(5). 586–599. 253 indexed citations
14.
Hoffmann, Florian, Peter Lohse, S Stojanov, et al.. (2004). Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation. European Journal of Human Genetics. 13(4). 510–512. 17 indexed citations
16.
Mallet, E., Bernd H. Belohradsky, Rosanna Lagos, et al.. (2003). A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety. Vaccine. 22(11-12). 1343–1357. 28 indexed citations
17.
Liese, Johannes G., et al.. (2001). Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. The Pediatric Infectious Disease Journal. 20(10). 981–988. 26 indexed citations
18.
Liese, Johannes G., S Stojanov, Pascal Minini, et al.. (2001). Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age. Vaccine. 20(3-4). 448–454. 16 indexed citations
19.
Stojanov, S. (1984). [Ovulation induction with clomiphene and dexamethasone].. PubMed. 106(9). 107–10. 1 indexed citations
20.
Stojanov, S. (1973). [Adrenogenital syndrome and pregnancy].. PubMed. 95(39). 1380–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026